- Home
- TLYS vs PBYI Comparison
TLYS vs PBYI Comparison
Compare TLYS & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLYS
- PBYI
- Stock Information
- Founded
- TLYS 1982
- PBYI 2010
- Country
- TLYS United States
- PBYI United States
- Employees
- TLYS N/A
- PBYI N/A
- Industry
- TLYS Clothing/Shoe/Accessory Stores
- PBYI Biotechnology: Pharmaceutical Preparations
- Sector
- TLYS Consumer Discretionary
- PBYI Health Care
- Exchange
- TLYS Nasdaq
- PBYI Nasdaq
- Market Cap
- TLYS 133.9M
- PBYI 153.2M
- IPO Year
- TLYS 2012
- PBYI N/A
- Fundamental
- Price
- TLYS $3.37
- PBYI $2.92
- Analyst Decision
- TLYS Hold
- PBYI Strong Buy
- Analyst Count
- TLYS 2
- PBYI 1
- Target Price
- TLYS $5.50
- PBYI $7.00
- AVG Volume (30 Days)
- TLYS 62.1K
- PBYI 416.5K
- Earning Date
- TLYS 12-05-2024
- PBYI 11-07-2024
- Dividend Yield
- TLYS N/A
- PBYI N/A
- EPS Growth
- TLYS N/A
- PBYI 492.79
- EPS
- TLYS N/A
- PBYI 0.47
- Revenue
- TLYS $595,185,000.00
- PBYI $243,569,000.00
- Revenue This Year
- TLYS N/A
- PBYI N/A
- Revenue Next Year
- TLYS $3.90
- PBYI N/A
- P/E Ratio
- TLYS N/A
- PBYI $6.26
- Revenue Growth
- TLYS N/A
- PBYI 6.30
- 52 Week Low
- TLYS $3.30
- PBYI $2.23
- 52 Week High
- TLYS $7.79
- PBYI $7.73
- Technical
- Relative Strength Index (RSI)
- TLYS 33.34
- PBYI 47.45
- Support Level
- TLYS $3.30
- PBYI $2.82
- Resistance Level
- TLYS $3.64
- PBYI $3.12
- Average True Range (ATR)
- TLYS 0.30
- PBYI 0.20
- MACD
- TLYS -0.09
- PBYI -0.03
- Stochastic Oscillator
- TLYS 4.76
- PBYI 14.71
About TLYS Tilly's Inc.
Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.